

We make it simple to add a clinically proven wound care modality to your practice with zero capital risk.
$0 upfront
FDA 510(k)-cleared Arobella AR1000 series (K131096)
Flexible ownership and lease options
QWTS Certification training, hands-on at your facility, completed in just a few hours
Nuvexa Practice Launch Package:
Patient eligibility verification support
Billing and coding guidance (CPT 97610, 11042 to 11047, 97597 to 97598)
IVR integration (optional)
Dedicated account support from day one
Covered by most major insurance plans
Compliance-forward structure built specifically for outpatient providers
Most practices cannot absorb a major capital equipment purchase and should not have to. Nuvexa's lease model was built to remove every barrier between your clinic and the most clinically advanced wound therapy technology available.
*Spots are limited. Nuvexa works with a select number of outpatient providers at a time to ensure white-glove onboarding.


Limb Salvage A diabetic patient had toes removed due to necrotic tissue and was scheduled for full amputation. QWTS was administered twice per week. The limb was saved (photos below)

Accelerated Amputation Recovery A diabetic patient at East Alabama Medical Center needed his second leg amputated. His doctor projected a full year of recovery before prosthetic fitting. After three months of QWTS treatment, the patient was cleared for his prosthetic, nine months ahead of schedule.
Graft Bed Preparation QWTS was used to prepare the wound bed for Apligraf grafting, resulting in significantly improved graft uptake (photos below)

Chronic Venous Insufficiency Two patients with non-healing wounds present for 3 to 12 months experienced outcomes ranging from significant healing to full closure after QWTS treatment.
Biofilm Removal QWTS was used for a complex biofilm case with visible healing progression documented through Day 49 (photos below)






